The $14.5 billion investment by the U.S. in the Human Genome Project, completed a decade ago, has paid off more than 60-fold in new jobs, drugs and a rapidly expanding genetics industry, an analysis has found.
Almost a decade after the U.S. human genome project was completed, scientists say they have mapped the underlying regulatory system that switches DNA on and off, potentially spurring a wave of new research into the molecular basis of complex diseases such as Type 1 diabetes.
On the fourth floor of a red brick medical building in Boston’s South End is an office where few want to go -- where people get a frequently unwelcome glimpse of their future through a careful reading of their DNA.
Scientists have discovered 193 hidden human proteins in an initiative that has produced the first comprehensive map of the human proteome, a research tool that may help drive new findings against disease.
The Wellcome Trust, the world’s second-biggest medical charity and a backer of the Human Genome Project and Alibaba Group Holding Ltd., is looking to sell $750 million in venture capital fund stakes as a resurgence of interest in the asset class lifts prices.